Algae oils firm Solazyme (San Francisco) filed on March 11 plans for an initial public offering (IPO) of up to $100 million which the company says it will use to fund R&D and capital expenditures. The company did not disclose pricing or a timeline for the offering. Solazyme's SEC filing says the company plans to accelerate its commercial strategy by accessing feedstock arrangements and establishing manufacturing capacity with partners.
展开▼